Japanese approval for Nycomed Pharma's surgical wound dressing:
This article was originally published in Clinica
Nycomed Pharma has received approval to market its TachoComb surgical wound dressing in Japan. When applied directly to a wound in organs such as the liver or lungs, the product's blood clotting factors and collagen fleece bond to stop diffuse bleeding and seal the tissue. Once the surgical wound has healed, the sealant resorbs into the body. TachoComb will be launched in Japan during the first quarter of 1999.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.